FBIO vs. SNY

Last updated Jul 11, 2026

FBIO (Fortress Biotech, Inc.) and SNY (Sanofi) are both stocks. Both are in the Healthcare sector — FBIO in Biotechnology, SNY in Drug Manufacturers - General. Over the past 10 years, FBIO returned -22.99%/yr vs 4.46%/yr for SNY. At a 0.13 correlation, their price movements are largely independent.

Performance

FBIO vs. SNY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Fortress Biotech, Inc. (FBIO) and Sanofi (SNY). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, FBIO achieves a -9.84% return, which is significantly lower than SNY's -5.25% return. Over the past 10 years, FBIO has underperformed SNY with an annualized return of -22.99%, while SNY has yielded a comparatively higher 4.46% annualized return.

FBIO

• 1D: 0.30%
• 1M: 19.57%
• 6M: -23.26%
• YTD: -9.84%
• 1Y: 74.60%
• 3Y*: -26.76%
• 5Y*: -42.40%
• 10Y*: -22.99%

SNY

• 1D: -0.91%
• 1M: -1.69%
• 6M: -6.36%
• YTD: -5.25%
• 1Y: -5.55%
• 3Y*: -1.13%
• 5Y*: 0.79%
• 10Y*: 4.46%

*Multi-year figures are annualized to reflect compound growth (CAGR)

FBIO vs. SNY - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
FBIO Fortress Biotech, Inc.	-9.84%	80.74%	-32.72%	-69.36%	-73.80%	-21.14%	23.35%	198.84%	-78.45%	47.78%
SNY Sanofi	-5.25%	4.93%	1.09%	6.55%	0.57%	7.00%	0.39%	20.47%	6.06%	9.96%

Correlation

The correlation between FBIO and SNY is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.08
Correlation (3Y) Calculated over the trailing 3-year period	0.09
Correlation (5Y) Calculated over the trailing 5-year period	0.10
Correlation (10Y) Calculated over the trailing 10-year period	0.14
Correlation (All Time) Calculated using the full available price history since Nov 17, 2011	0.13

Fundamentals

Market Cap FBIO : $109.62M SNY : $104.59B
EPS FBIO : -$0.20 SNY : €3.10
PS Ratio FBIO : 8.14 SNY : 1.96
PB Ratio FBIO : 18.46 SNY : 1.26
Total Revenue (TTM) FBIO : $63.25M SNY : €47.35B
Gross Profit (TTM) FBIO : $31.70M SNY : €34.18B
EBITDA (TTM) FBIO : -$21.61M SNY : €12.63B

Return for Risk

FBIO vs. SNY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FBIO

FBIO Risk / Return Rank: 71
FBIO Sharpe Ratio Rank: 71
FBIO Sortino Ratio Rank: 72
FBIO Omega Ratio Rank: 73
FBIO Calmar Ratio Rank: 71
FBIO Martin Ratio Rank: 67

SNY

SNY Risk / Return Rank: 31
SNY Sharpe Ratio Rank: 33
SNY Sortino Ratio Rank: 29
SNY Omega Ratio Rank: 29
SNY Calmar Ratio Rank: 30
SNY Martin Ratio Rank: 30

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FBIO vs. SNY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Fortress Biotech, Inc. (FBIO) and Sanofi (SNY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	FBIO	SNY	Difference
Sharpe ratio: Return per unit of total volatility	0.82	-0.27	+1.09
Sortino ratio: Return per unit of downside risk	1.57	-0.19	+1.76
Omega ratio: Gain probability vs. loss probability	1.21	0.98	+0.24
Calmar ratio: Return relative to maximum drawdown	1.34	-0.42	+1.76
Martin ratio: Return relative to average drawdown	2.30	-0.75	+3.05

FBIO vs. SNY - Sharpe Ratio Comparison

The current FBIO Sharpe Ratio is 0.82, which is higher than the SNY Sharpe Ratio of -0.27. The chart below compares the historical Sharpe Ratios of FBIO and SNY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

FBIO vs. SNY - Drawdown Comparison

The maximum FBIO drawdown since its inception was -99.27%, which is greater than SNY's maximum drawdown of -46.46%. Use the drawdown chart below to compare losses from any high point for FBIO and SNY.

Drawdown Indicators

	FBIO	SNY	Difference
Max Drawdown Largest peak-to-trough decline	-99.27%	-46.46%	-52.81%
Max Drawdown (1Y) Largest decline over 1 year	-49.32%	-16.70%	-32.62%
Max Drawdown (3Y) Largest decline over 3 years	-86.46%	-23.37%	-63.09%
Max Drawdown (5Y) Largest decline over 5 years	-97.61%	-33.52%	-64.09%
Max Drawdown (10Y) Largest decline over 10 years	-98.41%	-33.52%	-64.89%
Current Drawdown Current decline from peak	-98.17%	-19.31%	-78.86%
Average Drawdown Average peak-to-trough decline	-77.58%	-12.22%	-65.36%
Ulcer Index Depth and duration of drawdowns from previous peaks	28.76%	9.26%	+19.50%

Volatility

FBIO vs. SNY - Volatility Comparison

Fortress Biotech, Inc. (FBIO) has a higher volatility of 18.88% compared to Sanofi (SNY) at 8.41%. This indicates that FBIO's price experiences larger fluctuations and is considered to be riskier than SNY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	FBIO	SNY	Difference
Volatility (1M) Calculated over the trailing 1-month period	18.88%	8.41%	+10.47%
Volatility (6M) Calculated over the trailing 6-month period	48.06%	17.35%	+30.71%
Volatility (1Y) Calculated over the trailing 1-year period	80.27%	26.22%	+54.05%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	86.78%	25.02%	+61.76%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	85.21%	23.41%	+61.80%

Dividends

FBIO vs. SNY - Dividend Comparison

FBIO has not paid dividends to shareholders, while SNY's dividend yield for the trailing twelve months is around 5.57%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
FBIO Fortress Biotech, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
SNY Sanofi	5.57%	4.56%	4.22%	3.83%	4.32%	3.80%	3.61%	3.47%	4.29%	3.82%	4.11%	3.77%

Financials

Frequently Asked Questions

Can I hold both FBIO and SNY in my portfolio?

FBIO and SNY have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, FBIO or SNY?

FBIO has higher volatility (18.88%) compared to SNY (8.41%). In terms of maximum drawdown, FBIO dropped -99.27% vs SNY's -46.46%.

Which has better risk-adjusted returns?

FBIO currently has the higher Sharpe Ratio (0.82 vs -0.27), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.